AR079237A2 - Proceso para la preparacion de derivados de dibenzo(b,f) azepina - Google Patents
Proceso para la preparacion de derivados de dibenzo(b,f) azepinaInfo
- Publication number
- AR079237A2 AR079237A2 ARP100104442A ARP100104442A AR079237A2 AR 079237 A2 AR079237 A2 AR 079237A2 AR P100104442 A ARP100104442 A AR P100104442A AR P100104442 A ARP100104442 A AR P100104442A AR 079237 A2 AR079237 A2 AR 079237A2
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- preparation
- compound
- azepina
- dibenze
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un proceso para la preparacion de un compuesto de la formula (4) mediante hidrolisis de un compuesto de la formula (3) donde R1 es alquilo C1-4, donde el compuesto de la formula (3) se prepara mediante carbamoilacion de un compuesto de la formula (2) donde R1 es como se define para la formula (3), con un cianato de metal, donde la reaccion se efectua utilizando ácido acético, en presencia de un exceso sustancial de cianato de metal y en ausencia de un solvente adicional, donde dicho exceso substancial de cianato de metal es un exceso de por lo menos 0,2 equivalentes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0002740.9A GB0002740D0 (en) | 2000-02-07 | 2000-02-07 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR079237A2 true AR079237A2 (es) | 2012-01-04 |
Family
ID=9885081
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100515A AR029442A1 (es) | 2000-02-07 | 2001-02-05 | Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios |
ARP100104442A AR079237A2 (es) | 2000-02-07 | 2010-12-01 | Proceso para la preparacion de derivados de dibenzo(b,f) azepina |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100515A AR029442A1 (es) | 2000-02-07 | 2001-02-05 | Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios |
Country Status (34)
Country | Link |
---|---|
US (1) | US7112673B2 (es) |
EP (2) | EP1265868B1 (es) |
JP (1) | JP4859322B2 (es) |
KR (5) | KR20080103608A (es) |
CN (2) | CN1244563C (es) |
AR (2) | AR029442A1 (es) |
AT (2) | ATE505459T1 (es) |
AU (1) | AU767724B2 (es) |
BR (1) | BR0107922A (es) |
CA (3) | CA2395601C (es) |
CO (1) | CO5271705A1 (es) |
CY (1) | CY1111567T1 (es) |
CZ (1) | CZ301572B6 (es) |
DE (2) | DE60138271D1 (es) |
DK (1) | DK2067772T3 (es) |
ES (2) | ES2324900T3 (es) |
GB (1) | GB0002740D0 (es) |
HK (1) | HK1052501A1 (es) |
HU (1) | HU229420B1 (es) |
IL (3) | IL150613A0 (es) |
MX (1) | MXPA02007629A (es) |
MY (1) | MY136474A (es) |
NO (1) | NO324949B1 (es) |
NZ (1) | NZ520329A (es) |
PE (1) | PE20011078A1 (es) |
PL (2) | PL214039B1 (es) |
PT (2) | PT1265868E (es) |
RU (1) | RU2303591C2 (es) |
SI (1) | SI2067772T1 (es) |
SK (1) | SK287217B6 (es) |
TR (1) | TR200201655T2 (es) |
TW (1) | TWI284638B (es) |
WO (1) | WO2001056992A2 (es) |
ZA (1) | ZA200206219B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1302464A1 (en) * | 2001-10-09 | 2003-04-16 | Max India Limited | Process for preparation of 10-methoxycarbamazepine |
CA2407173C (en) | 2001-10-09 | 2009-09-29 | Max India Limited | Process for the preparation of 10-methoxycarbamazepine |
IL165694A0 (en) * | 2002-06-14 | 2006-01-15 | Taro Pharmaceuticals Usa Inc | Method of preparing a 5h-dibenzÄb,fÜazepine-5-carboxamide |
ITMI20040452A1 (it) | 2004-03-09 | 2004-06-09 | Clariant Lsm Italia Spa | Processo per la preparazione di oxcarbazepina |
PL1928454T3 (pl) | 2005-05-10 | 2015-03-31 | Intermune Inc | Pochodne pirydonu do modulowania układu kinazy białkowej aktywowanego stresem |
MX2008013675A (es) * | 2006-04-26 | 2009-03-06 | Supernus Pharmaceuticals Inc | Preparaciones de liberacion controlada de oxcarbacepina que tienen perfil de liberacion sigmoidal. |
US20090082335A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched oxcarbazepine |
CA3034994A1 (en) | 2008-06-03 | 2009-12-10 | Intermune, Inc. | Substituted aryl-2 pyridone compounds and use thereof for treating inflammatory and fibrotic disorders |
US20150232426A1 (en) | 2012-09-26 | 2015-08-20 | Ranbaxy Laboratories Limited | Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
CA2923835C (en) * | 2013-09-11 | 2022-11-29 | The Administrators Of The Tulane Educational Fund | Novel anthranilic amides and the use thereof |
KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847374A (en) * | 1987-01-27 | 1989-07-11 | Ciba-Geigy Corporation | Process for the manufacture of N,N-(Dibenzohexatrienylene)ureas |
IT1272897B (it) * | 1995-01-13 | 1997-07-01 | I F C Iniziative Finanziaarie | Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide |
US6355680B1 (en) * | 1996-02-20 | 2002-03-12 | Exocell, Inc. | Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
IT1283594B1 (it) * | 1996-04-12 | 1998-04-22 | Trifarma Srl | Derivati della 5h-dibenz- (b,f)-azepin-5-carbossiammide, loro preparazione e uso come sostanze ad azione medicinale |
NZ501277A (en) * | 1997-07-01 | 2002-12-20 | Warner Lambert Co | -2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors |
US6048856A (en) * | 1997-12-17 | 2000-04-11 | Novo Nordisk A/S | Heterocyclic compounds |
-
2000
- 2000-02-07 GB GBGB0002740.9A patent/GB0002740D0/en not_active Ceased
-
2001
- 2001-02-05 PE PE2001000121A patent/PE20011078A1/es not_active Application Discontinuation
- 2001-02-05 AR ARP010100515A patent/AR029442A1/es not_active Application Discontinuation
- 2001-02-06 MY MYPI20010513A patent/MY136474A/en unknown
- 2001-02-06 CO CO01008602A patent/CO5271705A1/es active IP Right Grant
- 2001-02-07 CN CNB018035302A patent/CN1244563C/zh not_active Expired - Lifetime
- 2001-02-07 WO PCT/EP2001/001330 patent/WO2001056992A2/en active Application Filing
- 2001-02-07 PT PT01915203T patent/PT1265868E/pt unknown
- 2001-02-07 EP EP01915203A patent/EP1265868B1/en not_active Expired - Lifetime
- 2001-02-07 IL IL15061301A patent/IL150613A0/xx unknown
- 2001-02-07 KR KR1020087027467A patent/KR20080103608A/ko not_active Application Discontinuation
- 2001-02-07 CN CNB2005100853024A patent/CN100455572C/zh not_active Expired - Lifetime
- 2001-02-07 RU RU2002123334/04A patent/RU2303591C2/ru not_active IP Right Cessation
- 2001-02-07 TR TR2002/01655T patent/TR200201655T2/xx unknown
- 2001-02-07 CA CA002395601A patent/CA2395601C/en not_active Expired - Fee Related
- 2001-02-07 KR KR1020097019039A patent/KR100966209B1/ko active IP Right Grant
- 2001-02-07 HU HU0300243A patent/HU229420B1/hu unknown
- 2001-02-07 JP JP2001556842A patent/JP4859322B2/ja not_active Expired - Lifetime
- 2001-02-07 KR KR1020107000738A patent/KR101216285B1/ko not_active IP Right Cessation
- 2001-02-07 DE DE60138271T patent/DE60138271D1/de not_active Expired - Lifetime
- 2001-02-07 PL PL356404A patent/PL214039B1/pl unknown
- 2001-02-07 CA CA2724295A patent/CA2724295C/en not_active Expired - Fee Related
- 2001-02-07 MX MXPA02007629A patent/MXPA02007629A/es active IP Right Grant
- 2001-02-07 PL PL392476A patent/PL217225B1/pl unknown
- 2001-02-07 ES ES01915203T patent/ES2324900T3/es not_active Expired - Lifetime
- 2001-02-07 PT PT09153375T patent/PT2067772E/pt unknown
- 2001-02-07 SI SI200130996T patent/SI2067772T1/sl unknown
- 2001-02-07 DE DE60144456T patent/DE60144456D1/de not_active Expired - Lifetime
- 2001-02-07 US US10/182,980 patent/US7112673B2/en not_active Expired - Lifetime
- 2001-02-07 CA CA2639210A patent/CA2639210C/en not_active Expired - Fee Related
- 2001-02-07 NZ NZ520329A patent/NZ520329A/en not_active IP Right Cessation
- 2001-02-07 AT AT09153375T patent/ATE505459T1/de active
- 2001-02-07 AT AT01915203T patent/ATE427938T1/de active
- 2001-02-07 SK SK1126-2002A patent/SK287217B6/sk not_active IP Right Cessation
- 2001-02-07 KR KR1020077029687A patent/KR100931753B1/ko not_active IP Right Cessation
- 2001-02-07 DK DK09153375.2T patent/DK2067772T3/da active
- 2001-02-07 BR BR0107922-0A patent/BR0107922A/pt not_active Application Discontinuation
- 2001-02-07 KR KR1020027010123A patent/KR20020071033A/ko not_active Application Discontinuation
- 2001-02-07 ES ES09153375T patent/ES2363490T3/es not_active Expired - Lifetime
- 2001-02-07 AU AU42373/01A patent/AU767724B2/en not_active Ceased
- 2001-02-07 CZ CZ20022676A patent/CZ301572B6/cs not_active IP Right Cessation
- 2001-02-07 EP EP09153375A patent/EP2067772B1/en not_active Expired - Lifetime
- 2001-02-09 TW TW090102908A patent/TWI284638B/zh not_active IP Right Cessation
-
2002
- 2002-07-04 IL IL150613A patent/IL150613A/en not_active IP Right Cessation
- 2002-07-26 NO NO20023575A patent/NO324949B1/no not_active IP Right Cessation
- 2002-08-05 ZA ZA200206219A patent/ZA200206219B/en unknown
-
2003
- 2003-05-13 HK HK03103369.4A patent/HK1052501A1/xx not_active IP Right Cessation
-
2007
- 2007-12-17 IL IL188183A patent/IL188183A/en not_active IP Right Cessation
-
2010
- 2010-12-01 AR ARP100104442A patent/AR079237A2/es unknown
-
2011
- 2011-06-16 CY CY20111100572T patent/CY1111567T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR079237A2 (es) | Proceso para la preparacion de derivados de dibenzo(b,f) azepina | |
AU2001252595A1 (en) | Process for producing optically active sulfoxide derivative | |
HRP20050413A2 (en) | A process for the mononitration of alkanediols | |
EP1690861A3 (en) | A process for preparing duloxetine and intermediates for use therein | |
ES2195510T3 (es) | Derivados de imidazopiridina y procedimiento para prepararlos. | |
BR0308345A (pt) | Processo para derivados de ácido trans-4-amino-1-cicloexanocarboxìlico | |
ATE217869T1 (de) | Verfahren zur herstellung von fluoralkenylthio heterozyclische derivate | |
DK1045823T3 (da) | Proces til fremstilling af visse benzoesyreforbindelser | |
BR0009453B1 (pt) | processo para a preparação de um composto. | |
AR051386A1 (es) | Proceso para compuestos triciclicos que contienen atomos heterogeneos | |
EP1132391A4 (en) | PRODUCTION METHOD FOR 3-SULFONYLOXY-3-CEPHEM COMPOUNDS | |
BR0112501A (pt) | Processo para a preparação de (-)mentol e compostos similares | |
UY26388A1 (es) | Procedimiento para la preparacion de compuestos de pirazolo (4,3-d) pirimidin - 7-onas-3- piridilsulfonilo e intermedios de los mismos. | |
DK709188D0 (da) | Fremgangsmaade til fremstilling af et pyrazolderivat | |
DK0662475T3 (da) | Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on. | |
MX9304677A (es) | Procedimiento para la preparacion de compuestos defenol polihidrico. | |
DK0391673T3 (da) | Fremstilling af glutarsyrederivater | |
DK1050526T3 (da) | Fremgangsmåde til fremstilling af en tertiær alkylester af en carboxylsyre | |
BR0011490A (pt) | Processo para a preparação de ésteres de 1,8-dissubstituìdos-1,3,4,9-tetrahidropirano (3,4-b)-indol-1-ácido acético em um solvente hidroxìlico | |
NO20034438D0 (no) | Fremgangsmåte for fremstilling av et 7-kinolyl-3,5- dihydroksyhept-6-enoeat | |
IT1298541B1 (it) | Processo per la preparazione di s-alchilcisteine | |
BR9810687B1 (pt) | processo para a preparação de um composto derivado de 2-alquiltiobenzonitrila. | |
AR026731A1 (es) | Procedimiento para fabricar tienopirimidinas | |
WO2005046854A3 (en) | A process for the preparation of diphenylmethylsulfinyl derivatives | |
AR016157A1 (es) | Proceso para preparar 3-ciano-8-azabiciclo[3.2.1]-octano, intermediarios 3-formilo y 3-epoxi-8-azabiciclo[3.2.1]-octanos y un proceso para preparar3-piridil-3-ciano-8-azabiciclo[3.2.1]-octanos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |